STOP-MSU: Stopping Haemorrhage With Tranexamic Acid for Hyperacute Onset Presentation Including Mobile Stroke Units
Status:
Recruiting
Trial end date:
2024-03-01
Target enrollment:
Participant gender:
Summary
The study is a prospective phase II randomised, double-blind, placebo-controlled
investigator-driven trial in acute intracerebral haemorrhage patients. The study has 2 arms
with 1:1 randomisation to either intravenous tranexamic acid or placebo and will test the
hypothesis that in patients with spontaneous ICH, treatment with tranexamic acid within 2
hours of onset will reduce haematoma expansion compared to placebo.
Phase:
Phase 2
Details
Lead Sponsor:
Neuroscience Trials Australia
Collaborator:
The Florey Institute of Neuroscience and Mental Health